BridgeBio Pharma, Inc. (BBIO)
66.28
+0.57
(+0.87%)
USD |
NASDAQ |
Sep 24, 16:00
66.40
+0.12
(+0.18%)
After-Hours: 04:27
BridgeBio Pharma Gross Profit (Annual) : 478.38M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 478.38M |
| December 31, 2024 | 214.35M |
| December 31, 2023 | 2.763M |
| December 31, 2022 | 69.84M |
| December 31, 2021 | 63.36M |
| Date | Value |
|---|---|
| December 31, 2020 | 5.161M |
| December 31, 2019 | 38.06M |
| December 31, 2018 | 0.00 |
| December 31, 2017 | -0.26M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 3.032B |
| Ionis Pharmaceuticals, Inc. | 915.36M |
| Pfizer Inc. | 41.04B |
| Vertex Pharmaceuticals, Inc. | 10.27B |
| BioMarin Pharmaceutical, Inc. | 2.505B |